About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05837533

Multicenter Study to Evaluate a Systematized Communication Model for Breast Cancer Patients

Both in Mexico and in the world, breast cancer is the most common malignancy in women. It is estimated that in 2020, 28.2% of the new cancer cases reported in our country correspond to breast cancer, ...

Lead sponsor: Medicos e Investigadores en la Lucha contra el Cancer de Mama•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Medicos e Investigadores en la Lucha contra el Cancer de Mama

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of de novo or recurrent metastatic breast cancer
•Candidate to start the first or second line of treatment for metastatic breast cancer

Exclusion Criteria

•Receipt of a line of treatment for metastatic breast cancer posterior to the second line

Related studies

RECRUITINGPhase 1/2

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

NCT05735080 · Breast Cancer, Breast Cancer Metastatic, and more

RECRUITINGPhase 3

Teen Driving Translation Study (NIH)

NCT05696353 · Drive, Recidivism, and more

RECRUITINGPhase 2

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

NCT07459673 · Breast Cancer, HER2-positive Breast Cancer, and more

Dime La VerDAD: Verify, Debunk, and Disseminate

NCT06417762 · Influenza, COVID-19, and more

RECRUITINGPhase 2

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

NCT06750484 · Breast Cancer Metastatic

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 7, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment100

Start dateMay 2023

Last updatedFeb 7, 2025

Condition

Breast Cancer Stage IV Breast Cancer Metastatic Communication

Locations shown

Hospital Zambrano Hellion

San Pedro Garza García, Nuevo León

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 7, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions